17-39727784-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004448.4(ERBB2):​c.3508C>G​(p.Pro1170Ala) variant causes a missense change. The variant allele was found at a frequency of 0.642 in 1,612,086 control chromosomes in the GnomAD database, including 341,648 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.52 ( 23709 hom., cov: 32)
Exomes 𝑓: 0.65 ( 317939 hom. )

Consequence

ERBB2
NM_004448.4 missense

Scores

5
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2O:1

Conservation

PhyloP100: 4.29

Publications

184 publications found
Variant links:
Genes affected
ERBB2 (HGNC:3430): (erb-b2 receptor tyrosine kinase 2) This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Allelic variations at amino acid positions 654 and 655 of isoform a (positions 624 and 625 of isoform b) have been reported, with the most common allele, Ile654/Ile655, shown here. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. Alternative splicing results in several additional transcript variants, some encoding different isoforms and others that have not been fully characterized. [provided by RefSeq, Jul 2008]
ERBB2 Gene-Disease associations (from GenCC):
  • Hirschsprung disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • lung cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • glioma susceptibility 1
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • visceral neuropathy, familial, 2, autosomal recessive
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.0380236E-5).
BP6
Variant 17-39727784-C-G is Benign according to our data. Variant chr17-39727784-C-G is described in ClinVar as Benign. ClinVar VariationId is 134082.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.658 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ERBB2NM_004448.4 linkc.3508C>G p.Pro1170Ala missense_variant Exon 27 of 27 ENST00000269571.10 NP_004439.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ERBB2ENST00000269571.10 linkc.3508C>G p.Pro1170Ala missense_variant Exon 27 of 27 1 NM_004448.4 ENSP00000269571.4

Frequencies

GnomAD3 genomes
AF:
0.523
AC:
79394
AN:
151918
Hom.:
23697
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.228
Gnomad AMI
AF:
0.771
Gnomad AMR
AF:
0.531
Gnomad ASJ
AF:
0.676
Gnomad EAS
AF:
0.395
Gnomad SAS
AF:
0.660
Gnomad FIN
AF:
0.682
Gnomad MID
AF:
0.620
Gnomad NFE
AF:
0.663
Gnomad OTH
AF:
0.540
GnomAD2 exomes
AF:
0.609
AC:
152231
AN:
249792
AF XY:
0.625
show subpopulations
Gnomad AFR exome
AF:
0.220
Gnomad AMR exome
AF:
0.569
Gnomad ASJ exome
AF:
0.689
Gnomad EAS exome
AF:
0.366
Gnomad FIN exome
AF:
0.682
Gnomad NFE exome
AF:
0.673
Gnomad OTH exome
AF:
0.634
GnomAD4 exome
AF:
0.654
AC:
955482
AN:
1460050
Hom.:
317939
Cov.:
52
AF XY:
0.657
AC XY:
477227
AN XY:
726106
show subpopulations
African (AFR)
AF:
0.220
AC:
7376
AN:
33456
American (AMR)
AF:
0.565
AC:
25214
AN:
44604
Ashkenazi Jewish (ASJ)
AF:
0.685
AC:
17821
AN:
26020
East Asian (EAS)
AF:
0.443
AC:
17569
AN:
39678
South Asian (SAS)
AF:
0.694
AC:
59769
AN:
86064
European-Finnish (FIN)
AF:
0.677
AC:
36119
AN:
53380
Middle Eastern (MID)
AF:
0.702
AC:
4038
AN:
5756
European-Non Finnish (NFE)
AF:
0.675
AC:
749705
AN:
1110778
Other (OTH)
AF:
0.628
AC:
37871
AN:
60314
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
18720
37439
56159
74878
93598
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19170
38340
57510
76680
95850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.522
AC:
79420
AN:
152036
Hom.:
23709
Cov.:
32
AF XY:
0.522
AC XY:
38817
AN XY:
74320
show subpopulations
African (AFR)
AF:
0.228
AC:
9459
AN:
41470
American (AMR)
AF:
0.532
AC:
8128
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.676
AC:
2346
AN:
3470
East Asian (EAS)
AF:
0.395
AC:
2027
AN:
5132
South Asian (SAS)
AF:
0.661
AC:
3182
AN:
4814
European-Finnish (FIN)
AF:
0.682
AC:
7220
AN:
10594
Middle Eastern (MID)
AF:
0.609
AC:
179
AN:
294
European-Non Finnish (NFE)
AF:
0.663
AC:
45034
AN:
67956
Other (OTH)
AF:
0.541
AC:
1142
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1685
3370
5055
6740
8425
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
684
1368
2052
2736
3420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.632
Hom.:
10206
Bravo
AF:
0.495
TwinsUK
AF:
0.670
AC:
2486
ALSPAC
AF:
0.667
AC:
2571
ESP6500AA
AF:
0.234
AC:
1033
ESP6500EA
AF:
0.657
AC:
5646
ExAC
AF:
0.605
AC:
73474
Asia WGS
AF:
0.559
AC:
1945
AN:
3478
EpiCase
AF:
0.679
EpiControl
AF:
0.672

ClinVar

Significance: Benign
Submissions summary: Benign:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.096
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.28
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.30
.;.;.;T;T
Eigen
Uncertain
0.42
Eigen_PC
Uncertain
0.45
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.84
.;T;T;T;T
MetaRNN
Benign
0.000010
T;T;T;T;T
MetaSVM
Benign
-0.88
T
MutationAssessor
Benign
0.69
.;.;.;.;N
PhyloP100
4.3
PrimateAI
Uncertain
0.61
T
PROVEAN
Benign
-2.3
.;N;N;N;N
REVEL
Benign
0.25
Sift
Benign
0.030
.;D;D;D;D
Sift4G
Benign
0.15
T;T;T;T;T
Polyphen
0.74, 0.94, 0.95
.;.;P;P;P
Vest4
0.17
MPC
0.93
ClinPred
0.034
T
GERP RS
5.0
Varity_R
0.12
gMVP
0.15
Mutation Taster
=60/40
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1058808; hg19: chr17-37884037; COSMIC: COSV54064104; COSMIC: COSV54064104; API